Patent: 9,346,769
✉ Email this page to a colleague
Summary for Patent: 9,346,769
Title: | Tetrazolones as inhibitors of fatty acid synthase |
Abstract: | Provided herein are tetrazolone FASN inhibitors of the formula (I): ##STR00001## or a pharmaceutically acceptable form thereof; wherein the variables R.sup.A, R.sup.B and R.sup.C are defined herein. Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections. |
Inventor(s): | Bahadoor; Adilah (Stittsville, CA), Castro; Alfredo C. (Winchester, MA), Chan; Lawrence K. (Brookline, MA), Keaney; Gregg F. (Lexington, MA), Nevalainen; Marta (Weymouth, MA), Nevalainen; Vesa (Weymouth, MA), Peluso; Stephane (Brookline, MA), Snyder; Daniel A. (Somerville, MA), Tibbitts; Thomas T. (Westford, MA) |
Assignee: | Infinity Pharmaceuticals, Inc. (Cambridge, MA) |
Application Number: | 13/975,236 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,346,769 |
Patent Claims: | see list of patent claims |
Details for Patent 9,346,769
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2030-05-05 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2030-05-05 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2030-05-05 | |
Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | 06/04/1986 | ⤷ Try a Trial | 2030-05-05 |
Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2030-05-05 |
Horizon Therapeutics Ireland Dac | ACTIMMUNE | interferon gamma-1b | Injection | 103836 | 02/25/1999 | ⤷ Try a Trial | 2030-05-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |